rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
2
|
pubmed:dateCreated |
2008-1-17
|
pubmed:abstractText |
Although mesenchymal stem cells (MSCs) show promising signs in reducing myocardial infarct (MI) size, the safety of endomyocardial delivery and the most efficacious dose is unknown.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0195-668X
|
pubmed:author |
pubmed-author:GhodsSusanS,
pubmed-author:HamamdzicDamirD,
pubmed-author:HashemiSeyed MSM,
pubmed-author:KeaneMartinM,
pubmed-author:KolodgieFrank DFD,
pubmed-author:LittHaroldH,
pubmed-author:Parcham-AzadKambizK,
pubmed-author:RippyMarian KMK,
pubmed-author:VirmaniRenuR,
pubmed-author:WilenskyRobert LRL,
pubmed-author:YoungRandellR
|
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
251-9
|
pubmed:meshHeading |
pubmed-meshheading:18073226-Animals,
pubmed-meshheading:18073226-Coronary Vessels,
pubmed-meshheading:18073226-Disease Models, Animal,
pubmed-meshheading:18073226-Female,
pubmed-meshheading:18073226-Infusions, Intralesional,
pubmed-meshheading:18073226-Magnetic Resonance Imaging, Cine,
pubmed-meshheading:18073226-Mesenchymal Stem Cell Transplantation,
pubmed-meshheading:18073226-Myocardial Infarction,
pubmed-meshheading:18073226-Myocardium,
pubmed-meshheading:18073226-Neovascularization, Physiologic,
pubmed-meshheading:18073226-Placebos,
pubmed-meshheading:18073226-Random Allocation,
pubmed-meshheading:18073226-Swine,
pubmed-meshheading:18073226-Ventricular Dysfunction, Left
|
pubmed:year |
2008
|
pubmed:articleTitle |
A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery after an acute myocardial infarction.
|
pubmed:affiliation |
Cardiovascular Division, Hospital of the University of Pennsylvania, Philadelphia, PA 19104, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|